September 25, 2012

HIV-associated fatigue in the era of highly active antiretroviral therapy: novel biological mechanisms?

I am convinced that our mitochondria are affected even after years off Zerit, DDI or AZT. Mitochondrial dysfunction has been widely reported with D drugs (D4T, DDI) and AZT and […]
September 19, 2012

FDA approved Jak inhibitors and their potential use in HIV – Interview with Dr Raymond Schinazi

As part of my work as a cure and salvage treatment activist, I am constantly searching for treatment options that could serve two purposes: existing medications […]
September 19, 2012

Fw: Hot Topics at TheBody.com’s “Ask the Experts” Forums

From: “News at The Body” <update@news.thebody.com> Date: 18 Sep 2012 18:37:02 -0400 To: <nelsonvergel@yahoo.com> ReplyTo: “News at The Body” <update@news.thebody.com> Subject: Hot Topics at TheBody.com’s “Ask […]
August 30, 2012

Gilead Prices Its New STRIBILD Once a Day HIV Regimen Higher Than Complera and Atripla

Gilead has priced its STRIBILD at  $28,500 / year.  The other two single tablet HIV regimens, Complera and Atripla cost $26, 350 /year and $24,971.64/year, respectively. […]